کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2484886 | 1114339 | 2012 | 12 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)âbâpoly(dlâlactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)âbâpoly(dlâlactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)âbâpoly(dlâlactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine](/preview/png/2484886.png)
چکیده انگلیسی
The histone deacetylase inhibitor suberoylanilide hydroxamic acid, known as vorinostat, is a promising anticancer drug with a unique mode of action; however, it is plagued by low water solubility, low permeability, and suboptimal pharmacokinetics. In this study, poly(ethylene glycol)âbâpoly(dlâlactic acid) (PEGâbâPLA) micelles of vorinostat were developed. Vorinostat's pharmacokinetics in rats was investigated after intravenous (i.v.) (10âmg/kg) and oral (p.o.) (50âmg/kg) micellar administrations and compared with a conventional polyethylene glycol 400 solution and methylcellulose suspension. The micelles increased the aqueous solubility of vorinostat from 0.2 to 8.15â± 0.60 and 10.24â± 0.92âmg/mL at drug to nanocarrier ratios of 1:10 and 1:15, respectively. Micelles had nanoscopic mean diameters of 75.67â± 7.57 and 87.33â± 8.62ânm for 1:10 and 1:15 micelles, respectively, with drug loading capacities of 9.93â± 0.21% and 6.91â± 1.19%, and encapsulation efficiencies of 42.74â± 1.67% and 73.29â± 4.78%, respectively. The micelles provided sustained exposure and improved pharmacokinetics characterized by a significant increase in serum halfâlife, area under curve, and mean residence time. The micelles reduced vorinostat clearance particularly after i.v. dosing. Thus, PEGâbâPLA micelles significantly improved the p.o. and i.v. pharmacokinetics and bioavailability of vorinostat, which warrants further investigation.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Pharmaceutical Sciences - Volume 101, Issue 10, October 2012, Pages 3787-3798
Journal: Journal of Pharmaceutical Sciences - Volume 101, Issue 10, October 2012, Pages 3787-3798
نویسندگان
Elham A. Mohamed, Yunqi Zhao, Mahasen M. Meshali, Connie M. Remsberg, Thanaa M. Borg, Abdel Monem M. Foda, Jody K. Takemoto, Casey L. Sayre, Stephanie E. Martinez, Neal M. Davies, M. Laird Forrest,